Loading…
Fennec Pharmaceuticals Inc. is projected to rise to $14.45 by 2027, a +38% move from its current price of $10.49. FENC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $10.24 | $10.50 | $10.77 | +0.08% |
| Jul 14 | $10.14 | $10.51 | $10.89 | +0.16% |
| Jul 15 | $10.06 | $10.52 | $10.99 | +0.24% |
| Jul 16 | $10.00 | $10.52 | $11.07 | +0.32% |
| Jul 17 | $9.95 | $10.53 | $11.14 | +0.40% |
| Jul 18 | $9.91 | $10.54 | $11.21 | +0.49% |
| Jul 19 | $9.87 | $10.55 | $11.28 | +0.57% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.87 | $10.55 | $11.28 | +0.57% |
| Week 2 | $9.65 | $10.61 | $11.66 | +1.14% |
| Week 3 | $9.50 | $10.67 | $11.98 | +1.71% |
| Week 4 | $9.39 | $10.73 | $12.27 | +2.28% |
| Week 5 | $9.29 | $10.79 | $12.53 | +2.86% |
| Week 6 | $9.21 | $10.85 | $12.78 | +3.45% |
| Week 7 | $9.14 | $10.91 | $13.03 | +4.03% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. Its product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients.
The company sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc.
for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited.
The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Fennec Pharmaceuticals Inc. (FENC) is the asset with a current price of $10.25 and a market capitalization of $356.05M, ranking 3338 by market cap.
The stock trades at $10.25 per share and has a market capitalization of $356.05M, ranking 3338. The forecast indicates a rising average price path from 2026 through 2050, with a 2050 average of $108.34 and a 2050 max of $198.49, suggesting notable upside potential over the long term.
Across years, the Avg price progresses from $10.25 in 2026 to $108.34 in 2050, with intermediate points including $13.89 (2027), $15.40 (2028), $16.77 (2029), $18.86 (2030), $20.61 (2031), $24.15 (2032), $30.60 (2033), $33.07 (2034), and $34.83 (2035). The forecast also shows large upside in later years, with 2040 Avg $54.68 and 2050 Avg $108.34; predicted ROIs rise from 0 in 2026 to 84 (2030), 433.4 (2040), and 957 (2050).
A major floor 45.0% below — a decisive break under it would weaken the trend.
The nearest floor, 17.1% below — buyers have tended to step in here.
The nearest ceiling, 5.1% above — a clean break opens room to run.
A major ceiling 18.2% above — clearing it would confirm fresh momentum.
Key FENC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FENC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.45 | Buy | $10.44 | Buy |
| MA 10 | $10.61 | Sell | $10.40 | Buy |
| MA 20 | $10.04 | Buy | $10.13 | Buy |
| MA 50 | $9.13 | Buy | $9.32 | Buy |
| MA 100 | $8.19 | Buy | $8.67 | Buy |
| MA 200 | $8.14 | Buy | $8.23 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.99 | Neutral |
| Stoch RSI (14) | 17.14 | Buy |
| CCI (20) | 43.98 | Neutral |
| Williams %R (14) | -36.00 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | 1.84 | Buy |
| Bollinger %B (20,2) | 0.65 | Neutral |
| Stochastic %K (14) | 64.00 | Neutral |
| TRIX (15) | 0.71 | Buy |
| Awesome (5,34) | 0.63 | Buy |
| Ultimate (7,14,28) | 51.04 | Neutral |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 10.29 | Buy |
| ADX (14) | 25.30 | Buy |
| ATR (14) | 0.22 | Info |
The 30-day technical picture is bullish. RSI14 is 60, SMA50 is $8.98, and SMA200 is $8.13. Support sits at $8.70 and resistance at $11.03, with a 30-day price range from $8.60 to $12.22.
Annualized volatility is 50%, indicating notable near-term price variability.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.77 | $10.49 | $15.42 | 0% | Neutral | |
| $11.58 | $14.45 | $19.02 | +38% | Bullish | |
| $12.67 | $16.22 | $22.10 | +55% | Bullish | |
| $13.66 | $17.86 | $25.01 | +70% | Bullish | |
| $15.40 | $20.51 | $29.38 | +96% | Bullish | |
| $16.78 | $22.73 | $33.22 | +117% | Bullish | |
| $19.52 | $26.87 | $39.98 | +156% | Bullish | |
| $24.43 | $34.12 | $51.60 | +225% | Bullish | |
| $26.13 | $37.01 | $56.81 | +253% | Bullish | |
| $27.38 | $39.31 | $61.19 | +275% | Bullish | |
| $41.69 | $63.60 | $104.96 | +506% | Bullish | |
| $76.06 | $128.66 | $231.26 | +11.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.77 | $10.49 | $12.40 | +0.00% |
| August 2026 | $9.10 | $10.72 | $12.95 | +2.22% |
| September 2026 | $9.52 | $11.29 | $13.78 | +5.30% |
| October 2026 | $9.67 | $11.52 | $14.19 | +2.06% |
| November 2026 | $9.79 | $11.73 | $14.54 | +1.75% |
| December 2026 | $10.27 | $12.35 | $15.42 | +5.33% |
Click any year to see its month-by-month FENC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The FENC price prediction for 2026 points to an average of $10.49 (low $5.77, high $15.42) — a potential gain of 0% on today's $10.49. A consolidation phase looks the most probable path here.
In 2027, FENC is projected to trade between $11.58 and $19.02, averaging $14.45 — a potential gain of +38% from today's $10.49. That is up +38% on the projected 2026 average. Momentum favours further upside here.
Fennec Pharmaceuticals Inc.'s 2028 outlook centres on $16.22, within a $12.67 to $22.10 range. That is up +12% on the projected 2027 average. That marks a +55% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, FENC could reach as high as $25.01, with a base case around $17.86 and support toward $13.66 — roughly +70% from $10.49. Momentum favours further upside here.
Expect FENC to range from $15.40 to $29.38 through 2030. The $20.51 average target implies a +96% move from current prices. That is up +15% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The FENC price prediction for 2031 points to an average of $22.73 (low $16.78, high $33.22) — a potential gain of +117% on today's $10.49. Momentum favours further upside here.
In 2032, FENC is projected to trade between $19.52 and $39.98, averaging $26.87 — a potential gain of +156% from today's $10.49. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Fennec Pharmaceuticals Inc.'s 2033 outlook centres on $34.12, within a $24.43 to $51.60 range. That is up +27% on the projected 2032 average. That marks a +225% change versus current levels. Momentum favours further upside here.
By 2034, FENC could reach as high as $56.81, with a base case around $37.01 and support toward $26.13 — roughly +253% from $10.49. Buyers look set to stay in control over this stretch.
Expect FENC to range from $27.38 to $61.19 through 2035. The $39.31 average target implies a +275% move from current prices. That is up +6% on the projected 2034 average. Momentum favours further upside here.
The FENC price prediction for 2040 points to an average of $63.60 (low $41.69, high $104.96) — a potential gain of +506% on today's $10.49. Buyers look set to stay in control over this stretch.
In 2050, FENC is projected to trade between $76.06 and $231.26, averaging $128.66 — a potential gain of +11.3x from today's $10.49. That is up +102% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in FENC today (≈ 95.328885 FENC) could be worth
$12,265.18
+$11,265.18 (+1127%) by 2050 · US Dollar
Based on the average projected FENC price of $128.66 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FENCwould be worth at today's price.
$1,000 invested in FENC on Jul 10, 2025 (≈ 110.619469 FENC) would be worth
$1,160.4
+$160.4 (+16.0%) today · 1.16× · US Dollar
Based on a FENC entry price of $9.04 vs. today's $10.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.7 | $980.37 | -2.0% |
| 1 month ago | $8.7 | $1,205.75 | +20.6% |
| 3 months ago | $5.81 | $1,805.51 | +80.6% |
| 6 months ago | $7.62 | $1,376.64 | +37.7% |
| 1 year ago | $9.04 | $1,160.4 | +16.0% |
| All time (5.0y) ago | $6.84 | $1,533.63 | +53.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FENC forecast.
Our base-case forecast reaches $21.00 around 2031.
Implied market cap at $21.00: $729.48M
2030 targets show a higher average price of $18.86 with a min of $14.03 and a max of $27.29, accompanied by an 84% ROI and a bullish sentiment.
2040 targets push the average to $54.68 with a min of $35.21 and a max of $91.69, accompanied by a 433.4 ROI and a bullish sentiment.
2050 targets push the average to $108.34 with a min of $62.40 and a max of $198.49, accompanied by a 957 ROI and a bullish sentiment.
The forecast indicates bullish sentiment across most years (2027 onward) and Neutral in 2026, with substantial upside potential but these figures are estimates, not guarantees, and carry inherent uncertainty.
Tap a question to reveal the answer.
2030 min $14.03; avg $18.86; max $27.29; ROI 84; sentiment BULLISH. These are forecast figures and not a guarantee of future results.
The forecast shows bullish sentiment in 2027, 2028, 2029, 2030, 2031, 2032, 2033, 2034, 2035, 2040 and 2050, with rising average prices from $13.89 (2027) to $108.34 (2050) and ROIs up to 957. These are estimates, not guarantees.
Yes. The 2034 max is $51.44, the 2040 max is $91.69, and the 2050 max is $198.49, indicating the potential to surpass $50 in the forecast horizon.
The 30-day range is $8.60 to $12.22, with RSI 60, SMA50 $8.98, SMA200 $8.13, support $8.70 and resistance $11.03; sentiment is BULLISH.
2050 min $62.40; avg $108.34; max $198.49; ROI 957; sentiment BULLISH. These figures illustrate substantial upside potential in the long term.
Fennec Pharmaceuticals Inc. Community Discussion
0Share your Fennec Pharmaceuticals Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.